Tempest Therapeutics Extends Warrant Issuance Deadline
The company issued a Pre-Funded Common Stock Purchase Warrant for a subscription of up to shares of common stock. The warrant allows the holder to purchase shares on or after September 11, 2026.
AI-generated summary for informational purposes only. Always verify against the original filing. Not investment advice. BriefTape is not a registered investment adviser.
Get real-time financial news in your trading bot or app
GET FREE KEY — 10,000 calls/day